Copyright Reports & Markets. All rights reserved.

Global Peptide Therapeutics Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Peptide Therapeutics by Type
    • 1.3.1 Overview: Global Peptide Therapeutics Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Peptide Therapeutics Consumption Value Market Share by Type in 2024
    • 1.3.3 Injection
    • 1.3.4 Oral
    • 1.3.5 Other
  • 1.4 Global Peptide Therapeutics Market by Application
    • 1.4.1 Overview: Global Peptide Therapeutics Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Cancer
    • 1.4.3 Metabolic Disorders
    • 1.4.4 Central Nervous System
    • 1.4.5 Other
  • 1.5 Global Peptide Therapeutics Market Size & Forecast
  • 1.6 Global Peptide Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global Peptide Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Peptide Therapeutics Market Size by Region, (2020-2031)
    • 1.6.3 North America Peptide Therapeutics Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Peptide Therapeutics Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Peptide Therapeutics Market Size and Prospect (2020-2031)
    • 1.6.6 South America Peptide Therapeutics Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Peptide Therapeutics Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Peptide Therapeutics Product and Solutions
    • 2.1.4 Sanofi Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Sanofi Recent Developments and Future Plans
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Peptide Therapeutics Product and Solutions
    • 2.2.4 Teva Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Teva Recent Developments and Future Plans
  • 2.3 Novo Nordisk
    • 2.3.1 Novo Nordisk Details
    • 2.3.2 Novo Nordisk Major Business
    • 2.3.3 Novo Nordisk Peptide Therapeutics Product and Solutions
    • 2.3.4 Novo Nordisk Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Novo Nordisk Recent Developments and Future Plans
  • 2.4 Takeda
    • 2.4.1 Takeda Details
    • 2.4.2 Takeda Major Business
    • 2.4.3 Takeda Peptide Therapeutics Product and Solutions
    • 2.4.4 Takeda Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Takeda Recent Developments and Future Plans
  • 2.5 Eli Lilly
    • 2.5.1 Eli Lilly Details
    • 2.5.2 Eli Lilly Major Business
    • 2.5.3 Eli Lilly Peptide Therapeutics Product and Solutions
    • 2.5.4 Eli Lilly Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Eli Lilly Recent Developments and Future Plans
  • 2.6 AstraZeneca
    • 2.6.1 AstraZeneca Details
    • 2.6.2 AstraZeneca Major Business
    • 2.6.3 AstraZeneca Peptide Therapeutics Product and Solutions
    • 2.6.4 AstraZeneca Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 AstraZeneca Recent Developments and Future Plans
  • 2.7 Novartis
    • 2.7.1 Novartis Details
    • 2.7.2 Novartis Major Business
    • 2.7.3 Novartis Peptide Therapeutics Product and Solutions
    • 2.7.4 Novartis Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Novartis Recent Developments and Future Plans
  • 2.8 AbbVie
    • 2.8.1 AbbVie Details
    • 2.8.2 AbbVie Major Business
    • 2.8.3 AbbVie Peptide Therapeutics Product and Solutions
    • 2.8.4 AbbVie Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 AbbVie Recent Developments and Future Plans
  • 2.9 Ipsen
    • 2.9.1 Ipsen Details
    • 2.9.2 Ipsen Major Business
    • 2.9.3 Ipsen Peptide Therapeutics Product and Solutions
    • 2.9.4 Ipsen Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Ipsen Recent Developments and Future Plans
  • 2.10 Ferring
    • 2.10.1 Ferring Details
    • 2.10.2 Ferring Major Business
    • 2.10.3 Ferring Peptide Therapeutics Product and Solutions
    • 2.10.4 Ferring Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Ferring Recent Developments and Future Plans
  • 2.11 Merck
    • 2.11.1 Merck Details
    • 2.11.2 Merck Major Business
    • 2.11.3 Merck Peptide Therapeutics Product and Solutions
    • 2.11.4 Merck Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Merck Recent Developments and Future Plans
  • 2.12 The Medicines
    • 2.12.1 The Medicines Details
    • 2.12.2 The Medicines Major Business
    • 2.12.3 The Medicines Peptide Therapeutics Product and Solutions
    • 2.12.4 The Medicines Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 The Medicines Recent Developments and Future Plans
  • 2.13 J & J
    • 2.13.1 J & J Details
    • 2.13.2 J & J Major Business
    • 2.13.3 J & J Peptide Therapeutics Product and Solutions
    • 2.13.4 J & J Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 J & J Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Peptide Therapeutics Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Peptide Therapeutics by Company Revenue
    • 3.2.2 Top 3 Peptide Therapeutics Players Market Share in 2024
    • 3.2.3 Top 6 Peptide Therapeutics Players Market Share in 2024
  • 3.3 Peptide Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 Peptide Therapeutics Market: Region Footprint
    • 3.3.2 Peptide Therapeutics Market: Company Product Type Footprint
    • 3.3.3 Peptide Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Peptide Therapeutics Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Peptide Therapeutics Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Peptide Therapeutics Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Peptide Therapeutics Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Peptide Therapeutics Consumption Value by Type (2020-2031)
  • 6.2 North America Peptide Therapeutics Market Size by Application (2020-2031)
  • 6.3 North America Peptide Therapeutics Market Size by Country
    • 6.3.1 North America Peptide Therapeutics Consumption Value by Country (2020-2031)
    • 6.3.2 United States Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Peptide Therapeutics Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Peptide Therapeutics Consumption Value by Type (2020-2031)
  • 7.2 Europe Peptide Therapeutics Consumption Value by Application (2020-2031)
  • 7.3 Europe Peptide Therapeutics Market Size by Country
    • 7.3.1 Europe Peptide Therapeutics Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 7.3.3 France Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Peptide Therapeutics Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Peptide Therapeutics Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Peptide Therapeutics Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Peptide Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific Peptide Therapeutics Consumption Value by Region (2020-2031)
    • 8.3.2 China Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 8.3.5 India Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Peptide Therapeutics Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Peptide Therapeutics Consumption Value by Type (2020-2031)
  • 9.2 South America Peptide Therapeutics Consumption Value by Application (2020-2031)
  • 9.3 South America Peptide Therapeutics Market Size by Country
    • 9.3.1 South America Peptide Therapeutics Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Peptide Therapeutics Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Peptide Therapeutics Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Peptide Therapeutics Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Peptide Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa Peptide Therapeutics Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Peptide Therapeutics Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Peptide Therapeutics Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Peptide Therapeutics Market Drivers
  • 11.2 Peptide Therapeutics Market Restraints
  • 11.3 Peptide Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Peptide Therapeutics Industry Chain
  • 12.2 Peptide Therapeutics Upstream Analysis
  • 12.3 Peptide Therapeutics Midstream Analysis
  • 12.4 Peptide Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Peptide Therapeutics market size was valued at US$ 42180 million in 2024 and is forecast to a readjusted size of USD 75590 million by 2031 with a CAGR of 8.8% during review period.
    Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
    Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
    North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
    In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
    This report is a detailed and comprehensive analysis for global Peptide Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Peptide Therapeutics market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Peptide Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Peptide Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Peptide Therapeutics market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Peptide Therapeutics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Peptide Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Peptide Therapeutics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Injection
    Oral
    Other
    Market segment by Application
    Cancer
    Metabolic Disorders
    Central Nervous System
    Other
    Market segment by players, this report covers
    Sanofi
    Teva
    Novo Nordisk
    Takeda
    Eli Lilly
    AstraZeneca
    Novartis
    AbbVie
    Ipsen
    Ferring
    Merck
    The Medicines
    J & J
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Peptide Therapeutics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Peptide Therapeutics, with revenue, gross margin, and global market share of Peptide Therapeutics from 2020 to 2025.
    Chapter 3, the Peptide Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Peptide Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Peptide Therapeutics.
    Chapter 13, to describe Peptide Therapeutics research findings and conclusion.

    Buy now